Skip to main content
SpringerLink
Log in

Endometrial Carcinoma

  • Chapter
Blaustein’s Pathology of the Female Genital Tract

Abstract

Endometrial carcinoma is the most common invasive neoplasm of the female genital tract and the fourth most frequently diagnosed cancer in the United States. In 1991 there were an estimated 33,000 new cases and approximately 4000 deaths resulting from this neoplasm.11,190 World-wide, approximately 150,000 cases are diagnosed each year, making endometrial carcinoma the fifth leading cancer in women.176 The incidence of endometrial cancer varies widely throughout the world. In developing countries in Asia, Africa, and South America as well as in Japan the incidence is four to five times lower than in industrialized countries in Europe and North America.67.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abeler VM, Kjorstad KE (1990) Serous papillary carcinoma of the endometrium: A histopathological study of 22 cases. Gynecol Oncol 39: 266–271

    PubMed  CAS  Google Scholar 

  2. Abeler VM, Kjorstad KE, Nesland JM (1991) Undifferentiated carcinoma of the endometrium. Cancer 68: 98–105

    PubMed  CAS  Google Scholar 

  3. Abeler VM, Kjorstad KE (1992) Endometrial adenocarcinoma with squamous cell differentiation. Cancer 69: 488–495

    PubMed  CAS  Google Scholar 

  4. Abeler VM, Kjorstad KE, Berle E (1992) Carcinoma of the endometrium in Norway: A histopathological and prognostic survey of a total population. Int J Gynecol Cancer 2: 9–22

    PubMed  Google Scholar 

  5. Alberhasky RC, Connelly PJ, Christopherson WM (1982) Carcinoma of the endometrium. IV. Mixed adenos-quamous carcinoma. A clinicopathological study of 68 cases with long-term follow-up. Am J Clin Pathol 77: 655

    PubMed  CAS  Google Scholar 

  6. Alders JG, Abeler V, Kolstad P (1984) Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patients. Gynecol Oncol 17: 64

    Google Scholar 

  7. Alders JG, Abeler V, Kolstad P (1982) Recurrent carcinoma of the endometrium: A clinical and pathological study of 379 patients. Gynecol Oncol 17: 85

    Google Scholar 

  8. Ambros RA, Kurman RJ (1992) Combined assessment of vascular and myometrial invasion as a model to predict prognosis in Stage 1 endometrioid adenocarcinoma of the uterine corpus. Cancer 69: 1424–1431

    PubMed  CAS  Google Scholar 

  9. Ambros RA, Kurman RJ (1992) Identification of patients with Stage 1 uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecol Oncol 45: 235–239

    PubMed  CAS  Google Scholar 

  10. Ambros RA, Kurman RJ (1993) Association of ulex europaeus agglutinin I binding with invasion in endometrial carcinoma. Int J Gynecol Pathol 12: 301–306

    PubMed  CAS  Google Scholar 

  11. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ (unpublished data)

    Google Scholar 

  12. American Cancer Society (1991) Cancer statistics. CA 41: 1.

    Google Scholar 

  13. Andersson M, Storm HH, Mouridsen HT (1991) Incidence of new primary cancers after adjuvant therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83: 1013–1017

    PubMed  CAS  Google Scholar 

  14. Arends J, Willebrand D, De Konigs, H, et al (1984) Adenocarcinoma of the endometrium with glassy cell features— immunohistochemical observations. Histopathology 8: 873–879

    PubMed  CAS  Google Scholar 

  15. Atkin NB (1976) Prognostic significance of ploidy level in human tumors. I. Carcinoma of the uterus. J Natl Cancer Inst 56: 909

    PubMed  CAS  Google Scholar 

  16. Aycock NR, Jollie WP, Dunn LJ (1979) An ultrastructural comparison of human endometrial adenocarcinoma with normal postmenopausal endometrium. Obstet Gynecol 53: 565

    PubMed  CAS  Google Scholar 

  17. Bannatyne P, Russell P, Wills EJ (1983) Argyrophilia and endometrial carcinoma. Int J Gynecol Pathol 2: 235

    PubMed  CAS  Google Scholar 

  18. Beck RP, Latour JPA (1963) Necropsy reports on 36 cases of endometrial carcinoma. Am J Obstet Gynecol 85: 307

    PubMed  CAS  Google Scholar 

  19. Beckner ME, Mori T, Silverberg SG (1985) Endometrial carcinoma: Non-tumor factors in prognosis. Int J Gynecol Pathol 4: 131

    PubMed  CAS  Google Scholar 

  20. Beller U, Beckman M, Twombly GH (1984) Spontaneous regression of advanced endometrial carcinoma. Gynecol Oncol 17: 381

    PubMed  CAS  Google Scholar 

  21. Benediktsdottir KR, Jonasson JG, Hallgrimsson J (1989) Tumours in Iceland: 12. Malignant tumours of the corpus of the uterus. APMIS 97: 781–786

    PubMed  CAS  Google Scholar 

  22. Berchuck A, Rodrigues G, Kinney RB, et al (1991) Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol 164: 15–21

    PubMed  CAS  Google Scholar 

  23. Bergeron C, Ferenczy A, Shyamala G (1988) Distribution of estrogen receptors in various cell types of normal, hyperplastic, and neoplastic human endometrial tissues. Lab Invest 58: 338–345

    PubMed  CAS  Google Scholar 

  24. Bergeron C, Ferenczy A, Toft DO, Shyamala G (1988) Immunocytochemical study of progesterone receptors in hyperplastic and neoplastic endometrial tissues. Cancer Res 48: 6132–6136

    PubMed  CAS  Google Scholar 

  25. Bitterman P, Chun BK, Kurman RJ (1990) The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohis-tochemical study. Am J Surg Pathol 14: 317–328

    PubMed  CAS  Google Scholar 

  26. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10

    PubMed  CAS  Google Scholar 

  27. Boltenberg A, Furgyik S, Kullander S (1990) Familial cancer aggregation in cases of adenocarcinoma corporis uteri. Acta Obstet Gynecol 69: 249–258

    CAS  Google Scholar 

  28. Borazjani G, Twiggs LB, Leung BS, Prem KA, Adcock LL, Carson LF (1989) Prognostic significance of steroid receptors measured in primary metastatic and recurrent endometrial carcinoma. Am J Obstet Gynecol 161: 1253–1257

    PubMed  CAS  Google Scholar 

  29. Boronow RC, Morrow CP, Creasman WT, et al (1984) Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstet Gynecol 63: 825–832

    PubMed  CAS  Google Scholar 

  30. Britton LC, Wilson TO, Gaffey TA, Lieber MM, Wieland HS, Podratz KC (1989) Flow cytometric DNA analysis of Stage 1 endometrial carcinoma. Gynecol Oncol 34: 317–322

    PubMed  CAS  Google Scholar 

  31. Bulletti C, Galassi A, Jasonni VM, Martinelli G, Tabanelli S, Flamigni C (1988) Basement membrane components in normal, hyperplastic and neoplastic endometrium. Cancer 62: 142–149

    PubMed  CAS  Google Scholar 

  32. Bunker M (1959) The terminal findings in endometrial carcinoma. Am J Obstet Gynecol 77: 530

    PubMed  CAS  Google Scholar 

  33. Bur ME, Perlman C, Edelmann L, Fey E, Rose PG (1992) p53 expression in neoplasms of the uterine corpus. Am J Clin Pathol 98: 81–87

    PubMed  CAS  Google Scholar 

  34. Cancer and Steroid Hormone Study of The Centers for Disease Control and The National Institute of Child Health and Human Development. Combination oral contraceptive use and the risk of endometrial cancer. JAMA (1987) 257: 796–800

    Google Scholar 

  35. Carcangiu ML, Chambers JT, Voynick IM, Pirro M, Schwartz PE (1990) Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Am J Clin Pathol 94: 247–254

    PubMed  CAS  Google Scholar 

  36. Carcangiu ML, Chambers JT (1992) Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 47: 298–305

    PubMed  CAS  Google Scholar 

  37. Cavazos F, Lucas RV (1973) Ultrastructure of the endometrium. In: Noms HJ, Hertig AT, Abel MR (eds) The uterus. Baltimore, Williams and Wilkins Co, p 136

    Google Scholar 

  38. Chalas E, Chumas J, Barbieri R, Mann WJ (1991) Nucleolar organizer regions in endometriosis, atypical endometriosis, and clear cell and endometrioid carcinomas. Gynecol Oncol 40: 260–263

    PubMed  CAS  Google Scholar 

  39. Chambers JT, MacLusky N, Eisenfield A, Kohorn El, Lawrence R, Schwartz PE (1988) Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer. Gynecol Oncol 31: 65–77

    PubMed  CAS  Google Scholar 

  40. Chambers JT, Carcangiu ML, Voynick IM, Schwartz PE (1990) Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival. Am J Clin Pathol 94: 255–260

    PubMed  CAS  Google Scholar 

  41. Charles D (1967) Endometrial adenoacanthoma. A clinicopathologic study of 55 cases. Cancer 18: 737

    Google Scholar 

  42. Charpin C, Andrac L, Habib MC, et al (1989) Immunocytochemical assays in human endometrial carcinomas: A multiparametric computerized analysis and comparison with nonmalignant changes. Gynecol Oncol 33: 9–22

    PubMed  CAS  Google Scholar 

  43. Chen J, Trost DC, Wilkinson EG (1985) Endometrial papillary adenocarcinomas: Two clinicopathologic types. Int J Gynecol Pathol 4: 279

    PubMed  CAS  Google Scholar 

  44. Chen KTK, Kostich ND, Rosai J (1978) Peritoneal foreign body granulomas to keratin in uterine adenoacanthoma. Arch Pathol Lab Med 108: 359

    Google Scholar 

  45. Cheon HK (1969) Prognosis of endometrial carcinoma. Obstet Gynecol 34: 680

    PubMed  CAS  Google Scholar 

  46. Christopherson WM, Alberhasky RC, Connelly PJ (1982) Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma. Cancer 49: 1511

    PubMed  CAS  Google Scholar 

  47. Christopherson WM, Alberhasky RC, Connell PJ (1982) Glassy cell carcinoma of the endometrium. Hum Pathol 13: 421

    Google Scholar 

  48. Christopherson WM, Alberhasky RC, Connell PJ (1982) Carcinoma of the endometrium. II. Papillary adenocarcinoma: A clinical pathological study of 46 cases. Am J Clin Pathol 77: 534

    PubMed  CAS  Google Scholar 

  49. Christopherson WM, Connelly PJ, Alberhasky RC (1983) Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and stage I disease. Cancer 51: 1705.

    PubMed  CAS  Google Scholar 

  50. Cohen C, Shulman G, Budgeon LR (1982) Endocervical and endometrial adenocarcinoma. An immunoperoxidase and histochemical study. Am J Surg Pathol 6: 151

    PubMed  CAS  Google Scholar 

  51. Coleman RL, Schink JC, Miller DS, et al (1993) DNA flow cytometric analysis of clinical stage. I. Endometrial carcinomas with lymph node metastasis. Gynecol Oncol 50: 20–24

    PubMed  CAS  Google Scholar 

  52. Connelly PJ, Alberhasky RC, Christopherson WM (1982) Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adeno-acanthoma. Obstet Gynecol 59: 569

    PubMed  CAS  Google Scholar 

  53. Coutrier J, Vielh P, Salmon R, et al (1988) Chromosome imbalance in endometrial adenocarcinoma. Cancer Genetic Cytogenet 33: 67–76

    Google Scholar 

  54. Cowles TA, Maglina JF, Masterson BJ, et al (1985) Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstet Gynecol 66: 413

    PubMed  CAS  Google Scholar 

  55. Creasman WT, DiSaia PJ, Blessing JA, et al (1981) Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 141: 921

    PubMed  CAS  Google Scholar 

  56. Creasman WT, Soper JT, McCarty KS Jr, McCarty KS Sr, Hinshaw W, Clarke-Pearson DL (1985) Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol 151: 922

    PubMed  CAS  Google Scholar 

  57. Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson DL (1986) Estrogen replacement therapy in the patient treated for endometrial carcinoma. Obstet Gynecol 67: 326

    PubMed  CAS  Google Scholar 

  58. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathological spread patterns of endometrial cancer: A Gynecologic Oncology Group study. Cancer 60: 2035–2041

    PubMed  CAS  Google Scholar 

  59. Creasman WT (1989) Announcement, FIGO stages: 1988 revisions. Gynecol Oncol 35: 125–127

    Google Scholar 

  60. Cullen TS (1900) Cancer of the uterus: Its pathology, symptomatology, diagnosis and treatment. New York, D. Appleton, p 374

    Google Scholar 

  61. Czernobilsky B, Katz Z, Lancet M, Galton E (1980) Endocervical-type epithelium in endometrial carcinoma. A report of 10 cases with emphasis on histochemical methods for differential diagnosis. Am J Surg Pathol 4: 481

    PubMed  CAS  Google Scholar 

  62. Dabbs DJ, Geisinger KR, Noms HJ (1986) Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 10: 568–576

    PubMed  CAS  Google Scholar 

  63. Daniel AG, Peters WA III (1988) Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol 71: 612–614

    PubMed  CAS  Google Scholar 

  64. DeBrito PA, Silverberg SG, Orenstein JM (1993) Carcinosarcoma (malignant mixed mullerian [mesodermal] tumor) of the female genital tract: Immunohistochemical and ultrastructural analysis of 28 cases. Hum Pathol 24: 132–142

    CAS  Google Scholar 

  65. Deligdisch L, Cohen CJ (1985) Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer 56: 1452

    PubMed  CAS  Google Scholar 

  66. Deligidish L, Holinka CF (1986) Progesterone receptors in two groups of endometrial carcinoma. Cancer 57: 1385–1388

    Google Scholar 

  67. Doering DL, Barnhill DR, Weiser ED, Burke TW, Woodward JE, Park RC (1989) Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol 74: 930–933

    PubMed  CAS  Google Scholar 

  68. Doll R, Muir Waterhouse J (1970) Cancer incidence in five continents. International Union Against Cancer. Berlin, Springer-Verlag, Vol 2, p 44.

    Google Scholar 

  69. Dunn LJ, Merchang JA, Bradbury JT, Stone DB (1968) Glucose tolerance and endometrial cancer: A controlled study. Arch Intern Med 121: 246

    PubMed  CAS  Google Scholar 

  70. Dunton CJ, Balsara G, McFarland M, Hernandez E (1991) Uterine papillary serous carcinoma: A review. Obstet Gynecol Surv 46: 97–102

    PubMed  CAS  Google Scholar 

  71. Dutra F (1959) Intraglandular morules of the endometrium. Am J Clin Pathol 31: 60

    PubMed  CAS  Google Scholar 

  72. Ehrlich CE, Young PCM, Cleary RE (1981) Cytoplasmic progesterone receptors in normal, hyperplastic, and carcinomatous endometrium: Therapeutic implications. Am J Obstet Gynecol 141: 539

    PubMed  CAS  Google Scholar 

  73. Ehrlich CE, Young PCM, Stehman FB, Sutton GP, Alford WM (1988) Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 158: 796–807

    PubMed  CAS  Google Scholar 

  74. Eifel P, Hendrickson M, Ross J, et al (1982) Simultaneous presentation of carcinoma involving the ovary and uterine corpus. Cancer 50: 163

    PubMed  CAS  Google Scholar 

  75. Elliott EA, Matanosla GM, Rosenshein NB, Grumbine FC, Diamond EL (1990) Body fat patterning in women with endometrial cancer. Gynecol Oncol 39: 253–258

    PubMed  CAS  Google Scholar 

  76. Elton NW (1942) Morphologic variations in adenocarcinoma of the fundus of the uterus, with reference to secretory activity and clinical interpretations. Am J Clin Pathol 12: 32

    Google Scholar 

  77. Emoto M, Iwasaki H, Kikuchi M, Shirakawa K (1993) Characteristics of cloned cells of mixed mullerian tumor of the human uterus. Cancer 71: 3065–3075

    PubMed  CAS  Google Scholar 

  78. Enomoto T, Inoue M, Perantoni AO, Teranaka N, Tanizawa O, Rice JM (1990) K-ras activation in neoplasms of the human female reproductive tract. Cancer Res 50: 6139–6145

    PubMed  CAS  Google Scholar 

  79. Enomoto T, Fujita M, Inoue M, et al (1991) Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res 51: 5308–5314

    PubMed  CAS  Google Scholar 

  80. Escobedo LG, Lee NC, Peterson HB, Wingo PA (1991) Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women. Obstet Gynecol 77: 124–128

    PubMed  CAS  Google Scholar 

  81. Factor SM (1974) Papillary adenocarcinoma of the endometrium with psammoma bodies. Arch Pathol 98: 201

    PubMed  CAS  Google Scholar 

  82. Fanning J, Evans MC, Peters AJ, Samuel M, Harmon ER, Bates JS (1989) Endometrial adenocarcinoma histologic subtypes: Clinical and pathologic profile. Gynecol Oncol 32: 288–291

    PubMed  CAS  Google Scholar 

  83. Farhi DC, Nosanchuk J, Silverberg SG (1986) Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 58: 741–745

    Google Scholar 

  84. Fluhmann CF (1928) Squamous epithelium in the endometrium in benign and malignant conditions. Surg Gynecol Obstet 47: 309

    Google Scholar 

  85. Fornander T, Cedermark B, Mattsson A, et al (1989) Adjuvant tamoxifen in early breast cancer. Occurrence of new primary cancer. Lancet i: 117–119

    Google Scholar 

  86. Franks AL, Kendrick JS, Tyler CW Jr (1987) Postmenopausal smoking, estrogen replacement therapy and the risk of endometrial cancer. Am J Obstet Gynecol 156: 20

    PubMed  CAS  Google Scholar 

  87. Frick HC, Munnell EW, Richart RM, Berger AP, Lawry MF (1973) Carcinoma of the endometrium. Am J Obstet Gynecol 115: 663

    PubMed  Google Scholar 

  88. Fu YS, Parks PJ, Reagen JW, Wentz WB, Storaasli JP (1979) The ultrastructure and factors relating to survival of endometrial cancers. Am J Diag Gynecol Obstet 1: 55

    Google Scholar 

  89. Fujimoto I, Shimizu Y, Hirai Y, et al (1993) Studies on ras oncogene in endometrial carcinoma. Gynecol Oncol 48: 196–202

    PubMed  CAS  Google Scholar 

  90. Fujita H, Wake N, Kutsuzawa T, et al (1985) Marker chromosomes of the long arm of chromosome 1 in endometrial carcinoma. Cancer Genet Cytogenet 18: 283–293

    PubMed  CAS  Google Scholar 

  91. Furness PN, Lam EW (1987) Patterns of basement membrane deposition in benign, premalignant and malignant endometrium. J Clin Pathol 40: 1320–1323

    PubMed  CAS  Google Scholar 

  92. Gal D, Recio FO, Zamubrovic D, Tancer ML (1991) Lymphvascular space involvement—A prognostic indicator in endometrial adenocarcinoma. Gynecol Oncol 42: 142–145

    PubMed  CAS  Google Scholar 

  93. Gallion HH, van Nagell JR, Powell DF, et al (1989) Stage I serous papillary carcinoma of the endometrium. Cancer 63: 2224–2228

    PubMed  CAS  Google Scholar 

  94. Gasparini G, Sposetti R, Pozza F, et al (1992) Multivariate analysis of prognostic factors in 232 patients with clinical stage 1 endometrial adenocarcinoma using the new FIGO surgical staging system. Int J Oncol 1: 665–672

    PubMed  CAS  Google Scholar 

  95. Geisinger KR, Homesley HD, Morgan TM, Kute TE, Marshall RB (1986) Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors. Cancer 58: 1518–1525

    PubMed  CAS  Google Scholar 

  96. George E, Manivel JC, Dehner LP, et al (1991) Malignant mixed mullerian tumors. An immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation. Hum Pathol 22: 215–223

    PubMed  CAS  Google Scholar 

  97. Glicksman AS, Rawson RW (1956) Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer 9: 1127

    PubMed  CAS  Google Scholar 

  98. Gorai I, Doi C, Minaguchi H (1993) Establishment and characterization of carcinosarcoma cell line of the human uterus. Cancer 71: 775–786

    PubMed  CAS  Google Scholar 

  99. Gray LA, Christopherson WM, Hoover RN (1977) Estrogens and endometrial carcinoma. Obstet Gynecol 49: 385

    PubMed  Google Scholar 

  100. Gray LA, Robertson RW, Christopherson WM (1971) Atypical endometrial changes associated with carcinoma. Gynecol Oncol 2: 93

    Google Scholar 

  101. Greenwald P, Caputo TA, Wolfgang PE (1977) Endometrial cancer after menopausal use of estrogens. Obstet Gynecol 50: 239

    PubMed  CAS  Google Scholar 

  102. Gronroos M, Salmi TA, Vuento MH, et al (1993) Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension. Cancer 71: 1279–1282

    PubMed  CAS  Google Scholar 

  103. Gusberg SB (1980) Current concepts in cancer. The changing nature of endometrial cancer. N Engl J Med 302: 729

    PubMed  CAS  Google Scholar 

  104. Gusberg SB (1989) Editorial. The rise and fall of endometrial cancer. Gynecol Oncol 35: 124

    PubMed  CAS  Google Scholar 

  105. Haenszel W, Kurihara M (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43–66

    PubMed  CAS  Google Scholar 

  106. Hall JB, Young RH, Nelson JH (1984) The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 17: 32

    PubMed  CAS  Google Scholar 

  107. Hanson MB, van Nagell JR Jr, Powell DE, et al (1985) The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 55: 1753

    PubMed  CAS  Google Scholar 

  108. Hendrickson E (1975) The lymphatic dissemination in endometrial carcinoma. A study of 188 necropsies. Am J Obstet Gynecol 123: 570

    Google Scholar 

  109. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R (1982) Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6: 93

    PubMed  CAS  Google Scholar 

  110. Hendrickson MR, Kempson RL (1983) Ciliated carcinoma—A variant of endometrial adenocarcinoma: A report of 10 cases. Int J Gynecol Pathol 2: 1

    PubMed  CAS  Google Scholar 

  111. Hernandez E, Woodruff JD (1980) Endometrial adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol 138: 827

    PubMed  CAS  Google Scholar 

  112. Hetzel D, Wilson T, Keeney G, et al (1992) HER-2/neu expression: A major prognostic factor in endometrial cancer. Gynecol Oncol 47: 179–185

    PubMed  CAS  Google Scholar 

  113. Hoffman MS, Cavanagh D, Walter TS, Ionata F, Ruffolo EH (1989) Adenocarcinoma of the endometrium and endometrioid carcinoma of the ovary associated with pregnancy. Gynecol Oncol 52: 82–85

    Google Scholar 

  114. Horgas G, Grubisic G, Spaventi S (1988) Trisomy and tetrasomy of the long arm of chromosome 1 in a direct preparation of human endometrial adenocarcinoma. Cancer Genet Cytogenet 35: 269–272

    PubMed  CAS  Google Scholar 

  115. Horowitz RI, Horowitz SM, Feinstein AR, et al. (1981) Necropsy diagnosis of endometrial cancer and detectionbias in case control studies. Lancet ii: 66

    Google Scholar 

  116. Hussain SF: (1988) Verrucous carcinoma of the endometrium. APMIS 96: 1075–1078

    PubMed  CAS  Google Scholar 

  117. Hustin J (1973) Hormonal therapy on endometrial cancer: Effects of large doses given by parenteral or intracavity routes. In: Brush MG, Taylor RW, Williams DC (eds) Symposium on endometrial cancer. London, Cassell Ltd, p 246

    Google Scholar 

  118. Ikeda M, Watanabe Y, Nanjob T, Noda K (1993) Evaluation of DNA ploidy in endometrial cancer. Gynecol Oncol 50: 25–29

    PubMed  CAS  Google Scholar 

  119. Inoue M, Ogawa H, Tanizawa O, Kobayashi Y, Tsujimoto M, Tsujimura T (1991) Immunodetection of sialyl-Tn antigen in normal, hyperplastic and cancerous tissues of the uterine endometrium. Virchows Arch A Pathol Anat 418: 157–162

    CAS  Google Scholar 

  120. Ignar-Trowbridge D, Risinger J, Dent G, et al. (1992) Mutations of the Ki-ras oncogene in endometrial carcinoma. Am J Obstet Gynecol 167: 227–232

    PubMed  CAS  Google Scholar 

  121. Inoue M, Nakayama M, Tanizawa O (1990) Altered expression of Lewis blood group and related antien in fetal, normal, and malignant tissues of the uterine endometrium. Virchows Arch (A) 416: 221–228

    CAS  Google Scholar 

  122. Jacques SM, Lawrence WD (1990) Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: A clinicopathologic study of 23 cases. Gynecol Oncol 37: 401–407

    PubMed  CAS  Google Scholar 

  123. Jones MA, Young RH, Scully RE (1991) Endometrial adenocarcinoma with a component of giant cell carcinoma. Int J Gynecol Pathol 10: 260–270

    PubMed  CAS  Google Scholar 

  124. Joseph MG, Fellows FG, Hearn SA (1990) Primary endodermal sinus tumor of the endometrium. Cancer 65: 297–302

    PubMed  CAS  Google Scholar 

  125. Kacinski B, Carter D, Mittal K, et al. (1988) High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. Int J Radiat Oncol Biol Phys 15: 823–829

    PubMed  CAS  Google Scholar 

  126. Kaku T, Silverberg SG, Tsukamoto N, et al. (1993) Association of endometrial epithelial metaplasias with endometrial carcinoma and hyperplasia in Japanese and American women. Int J Gynecol Pathol 12: 297–300

    PubMed  CAS  Google Scholar 

  127. Kanbour AI, Stock RJ (1978) Squamous cell carcinoma in situ of the endometrium and fallopian tube as superficial extension of invasive cervical carcinoma. Cancer 42: 570

    PubMed  CAS  Google Scholar 

  128. Kanbour-Shakir A, Tobon H (1991) Primary clear cell carcinoma of the endometrium: A clinicopathologic study of 20 cases. Int J Gynecol Pathol 10: 67–78

    PubMed  CAS  Google Scholar 

  129. Kim K, Scully RE (1990) Peritoneal keratin granulomas with carcinomas of endometrium and ovary and atypical polypoid adenomyoma of endometrium. Am J Surg Pathol 14: 925

    PubMed  CAS  Google Scholar 

  130. Kirkpatrick JB (1967) Pathogenesis of foam cell lesions in irradiated arteries. Am J Pathol 50: 291

    PubMed  CAS  Google Scholar 

  131. Kleine W, Maier T, Geyer H, Pfleiderer A (1990) Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance. Gynecol Oncol 38: 59–65

    PubMed  CAS  Google Scholar 

  132. Kohler MF, Berchuck A, Davidoff AM, et al (1992) Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52: 1622–1627

    PubMed  CAS  Google Scholar 

  133. Koss LG, Schreiber K, Oberlander SG, Moussouris HF, Lesser M (1984) Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstet Gynecol 64: 1–11

    PubMed  CAS  Google Scholar 

  134. Kraus FT (1973) Irradiation changes in the uterus. In: Noms HJ, Hertig AT, Abell MR (eds) The uterus. Baltimore, William and Wilkins Co, p 457

    Google Scholar 

  135. Kumar A, Schneider V (1983) Metastases to the uterus from extrapelvic primary tumors. Int J Gynecol Pathol 2: 134

    PubMed  CAS  Google Scholar 

  136. Kumar NB, Hart WR (1982) Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer 50: 2163

    PubMed  CAS  Google Scholar 

  137. Kuramoto H, Hamano M (1977) Cytogenetic studies of human endometrial carcinoma by means of tissue culture. Acta Cytol 4: 559–565

    Google Scholar 

  138. Kurman RJ, Noms HJ (1982) Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well differentiated carcinoma. Cancer 49: 2547

    PubMed  CAS  Google Scholar 

  139. Kurman RJ, Scully RE (1976) Clear cell carcinoma of the endometrium. An analysis of 21 cases. Cancer 37: 872

    PubMed  CAS  Google Scholar 

  140. Kurman RJ, Kaminski PF, Noms HJ (1985) The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 56: 403

    PubMed  CAS  Google Scholar 

  141. Lauchlan SC (1981) Tubai (serous) carcinoma of the endometrium. Arch Pathol 105: 615

    CAS  Google Scholar 

  142. Lee KR, Belinson JL (1991) Recurrence in noninvasive endometrial carcinoma. Am J Surg Pathol 15: 965–973

    PubMed  CAS  Google Scholar 

  143. Lee RB, Burke TW, Park RC (1990) Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol 36: 189–191

    PubMed  CAS  Google Scholar 

  144. Lesko SM, Rosenberg L, Kaufman DW, et al (1985) Cigarette smoking and the risk of endometrial cancer. N Engl J Med 313: 593

    PubMed  CAS  Google Scholar 

  145. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS Jr (1988) Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. Endocrinol Metab 67: 334–340

    CAS  Google Scholar 

  146. Levenback C, Burke TW, Silva E, et al (1992) Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol 46: 317–321

    PubMed  CAS  Google Scholar 

  147. Levi F, Franceschi S, Negri E, La Vecchia C (1993) Dietary factors and the risk of endometrial cancer. Cancer 71: 3575–3581

    PubMed  CAS  Google Scholar 

  148. Lewis BV, Stallworthy JA, Cowdell R (1970) Adenocarcinoma of the body of the uterus. J Obstet Gynaecol Br Commonw 77: 343

    PubMed  CAS  Google Scholar 

  149. Lindahl B, Alm P, Ferno M, Norgren A, Trope C (1984) Plasma steroid hormones, cytosol receptors, and thymidine incorporation rate in endometrial carcinoma. Am J Obstet Gynecol 149: 607

    PubMed  CAS  Google Scholar 

  150. LiVolsi VA (1977) Adenocarcinoma of the endometrium with psammoma bodies. Obstet Gynecol 50: 725

    PubMed  CAS  Google Scholar 

  151. Long CA, O’Brien TJ, Sanders MM, Bard DS, Quirk JG Jr (1988) A ras oncogene is expressed in adenocarcinoma of the endometrium. Am J Obstet Gynecol 159: 1512–1515

    PubMed  CAS  Google Scholar 

  152. Longscope C, Pratt JH, Schneider SH, Fineberg SE (1978) Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metabl 46: 146

    Google Scholar 

  153. Lucas WE, Yen SSC (1979) A study of endocrine and metabolic variables in postmenopausal women with endometrial carcinoma. Am J Obstet Gynecol 134: 180

    PubMed  CAS  Google Scholar 

  154. Lutz MH, Underwood PB Jr, Kreutner A Jr, et al (1978) Endometrial carcinoma: A method of classification of therapeutic and prognostic significance. Gynecol Oncol 6: 83

    PubMed  CAS  Google Scholar 

  155. Lynch HT, Krush AH, Larsen AL (1967) Heredity and endometrial carcinoma. South Med J 60: 231

    PubMed  CAS  Google Scholar 

  156. Mack TM, Pike MC, Henderson BE, et al (1976) Estrogens and endometrial cancer in a retirement community. N Engl J Med 294: 1262

    PubMed  CAS  Google Scholar 

  157. McDonald TW, Annegers JF, O’Fallon WM, Dockerty MB, Malkasian GD, Kurland LT (1977) Exogenous estrogen and endometrial carcinoma: Case-control and incidence study. Am J Obstet Gynecol 127: 572

    PubMed  CAS  Google Scholar 

  158. McLellan R, Dillon MB, Currie JL, Rosenshein NB (1989) Peritoneal cytology in endometrial cancer: A review. Obstet Gynecol Surv 44: 711–719

    PubMed  CAS  Google Scholar 

  159. Mecklin J-P, Jarvinen HJ, Peltopallio P (1986) Cancer family syndrome: Genetic analysis of 22 Finnish kindreds. Gastroenterology 90: 328–333

    PubMed  CAS  Google Scholar 

  160. Meis JM, Lawrence WD (1990) The immunohistochemical profile of malignant mixed mullerian tumor. Overlap with endometrial adenocarcinoma. Am J Clin Pathol 94: 1–7

    PubMed  CAS  Google Scholar 

  161. Melhem MF, Tobon H (1987) Mucinous adenocarcinoma of the endometrium: A clinicopathological review of 18 cases. Int J Gynecol Pathol 6: 347–355

    PubMed  CAS  Google Scholar 

  162. Melin JR, Wanner L, Schulz DM, Cassell EE (1979) Primary squamous cell carcinoma of the endometrium. Obstet Gynecol 53: 115

    PubMed  CAS  Google Scholar 

  163. Mitchell H, Giles G, Medley G (1993) Accuracy and survival benefit of cytological prediction of endometrial carcinoma on routine cervical smears. Int J Gynecol Pathol 12: 34–40

    PubMed  CAS  Google Scholar 

  164. Mittal KR, Barwick KW (1993) Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis. Gynecol Oncol 49: 197–201

    PubMed  CAS  Google Scholar 

  165. Mizuuchi W, Masims S, Kudo R, et al (1992) Clinical implications of K-Ras mutations in malignant epithelial tumors of the endometrium. Cancer Res 52: 2777–2781

    PubMed  CAS  Google Scholar 

  166. Morrow CP, Bundy BN, Kurman RJ, et al (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 40: 55–65

    PubMed  CAS  Google Scholar 

  167. Musubuchi K, Nemoto H (1972) Epidemiologic studies on uterine cancer at Cancer Institute Hospital, Tokyo, Japan. Cancer 30: 268

    Google Scholar 

  168. Nahhas WA, Lund CJ, Rudolph JH (1971) Carcinoma of the corpus uteri: A 10-year review of 225 patients. Obstet Gynecol 38: 564

    PubMed  CAS  Google Scholar 

  169. Ng ABP (1968) Mixed carcinoma of the endometrium. Am J Obstet Gynecol 102: 506

    PubMed  CAS  Google Scholar 

  170. Ng ABP, Reagan JW, Storaasli JP, Wentz WB (1973) Mixed adenosquamous carcinoma of the endometrium. Am J Clin Pathol 59: 765

    PubMed  CAS  Google Scholar 

  171. Nielsen AL, Thomsen HK, Nyholm HCJ (1991) Evaluation of the reproducibility of the revised 1988 International Federation of Gynecology and Obstetrics grading system of endometrial cancers with special emphasis on nuclear grading. Cancer 68: 2303–2309

    PubMed  CAS  Google Scholar 

  172. Nielsen AN, Nyholm HCJ (1993) Proliferating cell nuclear antigen in endometrial adenocarcinomas of endometrioid type correlated with histologie grade, stage, previous hormonal treatment, and survival. Hum Pathol 24: 1003–1007

    PubMed  CAS  Google Scholar 

  173. Noumoff JS, Menzin A, Mikuta J, Lusk EJ, Morgan M, LiVolsi VA (1991) The ability to evaluate prognostic variable on frozen section in hysterectomies performed for endometrial carcinoma. Gynecol Oncol 42: 202–208

    PubMed  CAS  Google Scholar 

  174. Novak ER, Nalley WB (1957) Uterine adenocanthoma. Obstet Gynecol 9: 396

    PubMed  CAS  Google Scholar 

  175. Nyholm HCJ, Nielsen AL, Norup P (1993) Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment: Comparison of clinical and histopathological characteristics. Gynecol Oncol 49: 229–235

    PubMed  CAS  Google Scholar 

  176. Nyholm HCJ, Nielsen AL, Ottesen B (1993) Expression of epidermal growth factor receptors in human endometrial carcinoma. Int J Gynecol Pathol 12: 241–245

    PubMed  CAS  Google Scholar 

  177. Okamoto A, Sameshima Y, Yamada Y, et al. (1991) Allelic loss of chromosome 17p and p53 mutation in human endometrial carcinoma of the uterus. Cancer Res 51: 5632–5636

    PubMed  CAS  Google Scholar 

  178. Palmer DC, Muir IM, Alexander AI, Cauchi M, Bennett RC, Quinn MA (1988) The prognostic importance of steroid receptors in endometrial carcinoma. Obstet Gynecol 72: 388–393

    PubMed  CAS  Google Scholar 

  179. Pararzzini F, La Vecchia C, Bocciolone L, Franceschi S (1991) The epidemiology of endometrial cancer. Gynecol Oncol 41: 1–16

    Google Scholar 

  180. Persson I, Adami H-O, Bergkvist L, et al. (1989) Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: Results of a prospective study. Br Med J 298: 147

    CAS  Google Scholar 

  181. Pesce C, Merino MJ, Chambers JT, Nogales F (1991) Endometrial carcinoma with trophoblastic differentiation. Cancer 68: 1799–1802

    PubMed  CAS  Google Scholar 

  182. Peterson EP (1968) Endometrial carcinoma in young women. A clinical profile. Obstet Gynecol 31: 702

    PubMed  CAS  Google Scholar 

  183. Photopulos GJ, Carney CN, Edelman DA, Hughes RR, Fowler WC Jr, Walton LA (1979) Clear cell carcinoma of the endometrium. Cancer 43: 1448–1456

    PubMed  CAS  Google Scholar 

  184. Piver MS, Lele S, Barlow J, et al (1982) Parraortic lymph node evaluation in stage I endometrial cancer. Obstet Gynecol 59: 97

    PubMed  CAS  Google Scholar 

  185. Podczaski E, Kaminski P, Gursfi K, et al. (1992) Detection and patterns of treatment failure in 300 consecutive cases of early endometrial cancer after primary surgery. Gynecol Oncol 47: 323–327

    PubMed  CAS  Google Scholar 

  186. Podczaski E, Kaminski P, Zaino R (1993) CA125 and CAI9-9 immunolocalization in normal, hyperplastic and carcinomatous endometrium. Cancer 71: 2551–2556

    PubMed  CAS  Google Scholar 

  187. Prem KA, Mensheha NM, McKelvey JL (1965) Operative treatment in adenocarcinoma of the endometrium in obese women. Am J Obstet Gynecol 92: 16

    PubMed  CAS  Google Scholar 

  188. Press MF, Nousek-Goebel N, Greene GL (1985) Immunoelectron microscopic localization of estrogen receptor with monoclonal estrophilin antibodies. J Histochem Cytochem 33: 915

    PubMed  CAS  Google Scholar 

  189. Press MF, Udove JA, Greene GL (1988) Progesterone receptor distribution in human endometrium. Analysis using monoclonal antibodies to the human progesterone receptor. Am J Pathol 131: 112–124

    PubMed  CAS  Google Scholar 

  190. Quinn CM, Wright AA (1990) The clinical assessment of proliferation and growth in human tumors: Evaluation of methods and applications as prognostic variables. J Pathol 160: 93–102

    PubMed  CAS  Google Scholar 

  191. Ramirez-Gonzalex CE, Adamsons K, Mangual-Vazquez TY, Wallach RC (1987) Papillary adenocarcinoma in the endometrium. Obstet Gynecol 70: 212–214

    Google Scholar 

  192. Richart RM, Ferenczy A (1974) Endometrial morphologie response to hormonal environment. Gynecol Oncol 2: 180

    PubMed  CAS  Google Scholar 

  193. Ries LAG, Hankey BF, Miller BA, Hartman AM, Edwards BK (1991) Cancer Statistics Review 1973-1978. National Cancer Institute. NIH Pub. No. 91-2789

    Google Scholar 

  194. Risberg B, Grotott O, Westholm B (1983) Origin of carcinoma in secretory endometrium—A study using a whole organ sectioning technique. Gynecol Oncol 15: 32

    PubMed  CAS  Google Scholar 

  195. Robboy SJ, Bradley R (1979) Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy. Obstet Gynecol 54: 269

    PubMed  CAS  Google Scholar 

  196. Robboy SJ, Miller AW III, Kurman RJ (1982) The pathologic features and behavior of endometrial carcinoma associated with exogenous estrogen administration. Pathol Res Pract 174: 237

    PubMed  CAS  Google Scholar 

  197. Roberts DWT (1961) Carcinoma of the body of the uterus at Chelsea Hospital for Women, 1943-1953. J Obstet Gynaecol Br Commonw 68: 132

    CAS  Google Scholar 

  198. Rorat E, Ferenczy A, Richart RM (1974) The ultrastructure of clear cell adenocarcinoma of endometrium. Cancer 33: 880

    PubMed  CAS  Google Scholar 

  199. Ross J, Eifel PH, Cox RS, Kempson RL, Hendrickson MR (1983) Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol 7: 715

    PubMed  CAS  Google Scholar 

  200. Runowicz CD, Nuchtern LM, Rraunstein JD, Jones JG (1990) Heterogeneity in hormone receptor status in primary and metastatic endometrial cancer. Gynecol Oncol 38: 437–441

    PubMed  CAS  Google Scholar 

  201. Ryder DE (1982) Verrucous carcinoma of the endometrium—a unique neoplasm with long survival. Obstet Gynecol 59: 78S–80S

    PubMed  CAS  Google Scholar 

  202. Salazar OM, DePapp EW, Bonfiglio TA, Feldstein MK, Rubin P, Rudolph JH (1977) Adenosquamous carcinoma of the endometrium. An entity with an inherently poor prognosis? Cancer 40: 119

    PubMed  CAS  Google Scholar 

  203. Salazar OM, Feldstein ML, De Papp EW, et al (1977) Endometrial carcinoma: Analysis of failures with special emphasis on the use of initial preoperative external pelvic radiation. Int J Radiat Oncol Biol Phys 2: 1101

    PubMed  CAS  Google Scholar 

  204. Salm R (1962) Mucin production of normal and abnormal endometrium. Arch Pathol 73: 30

    PubMed  CAS  Google Scholar 

  205. Sandles LG, Shulman LP, Elias S, et al. (1992) Endometrial adenocarcinoma: Genetic analysis suggesting heritable sitespecific uterine cancer. Gynecol Oncol 47: 167–171

    PubMed  CAS  Google Scholar 

  206. Sassano H, Nagura H, Watanabe K, et al. (1993) Tenascin expression in normal and abnormal human endometrium. Mod Pathol 6: 323–326

    Google Scholar 

  207. Sato N, Mori T, Orenstein JM, Silverberg SG (1984) Ultrastructure of papillary serous carcinoma of the endometrium. Int J Gynecol Pathol 2: 337

    PubMed  CAS  Google Scholar 

  208. Schenker JG, Weinstein D, Okon E (1979) Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer. Cancer 44: 1809

    PubMed  CAS  Google Scholar 

  209. Scully RE, Poulson H, Sobin LH (1994) International histological classification and histologic typing of female genital tract tumors. Berlin, Springer-Verlag

    Google Scholar 

  210. Scully RE, Aguirre P, DeLellis RA (1984) Argyrophilia, serotonin, and peptide hormones in the female genital tract and its tumors. Int J Gynecol Pathol 3: 51

    PubMed  CAS  Google Scholar 

  211. Scully RE, Richardson G, Barlow JF (1966) The development of malignancy in endometriosis. Clin Obstet Gynecol 9: 384

    PubMed  CAS  Google Scholar 

  212. Segreti EM, Novotny DB, Soper JT, Mutch DG, Creasman WT, McCarty KS (1989) Endometrial cancer: Histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor. Obstet Gynecol 73: 780–784

    PubMed  CAS  Google Scholar 

  213. Sekiya S, Takeda B, Kikuchi Y, Sakaguchi S, Takamizawa H (1977) Morphologic and enzyme-cytochemical changes in uterine adenocarcinoma cells of a rat by direct application of progesterone in vitro. Gynecol Oncol 5: 5

    PubMed  CAS  Google Scholar 

  214. Seoud M A-F, Johns J, Weed JC Jr (1993) Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 82: 165–169

    PubMed  CAS  Google Scholar 

  215. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ (1992) Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 16: 600–610

    PubMed  CAS  Google Scholar 

  216. Shim JU, Rose PG, Reale FR, Soto H, Tak WK, Hunter RE (1992) Accuracy of frozen-section diagnosis at surgery in clinical stage I and II endometrial carcinoma. Am J Obstet Gynecol 166: 1335–1338

    PubMed  CAS  Google Scholar 

  217. Silva EG, Jenkins R (1990) Serous carcinoma in endometrial polyps. Mod Pathol 3: 120–128

    PubMed  CAS  Google Scholar 

  218. Silverberg SG, DeGiorgi LS (1973) Clear cell carcinoma of the endometrium: Clinical, pathologic, and ultrastructural findings. Cancer 31: 1127

    PubMed  CAS  Google Scholar 

  219. Silverberg SG, Sasano N, Yajima A (1982) Endometrial carcinoma in Miyagi Perfecture, Japan: Histopathologic analysis of a cancer-based series and comparison with cases in American women. Cancer 49: 1504

    PubMed  CAS  Google Scholar 

  220. Silverberg SG, Mullen D, Faraci JA, et al. (1980) Endometrial carcinoma: Clinical-pathologic comparison of cases in postmenopausal women receiving and not receiving estrogens. Cancer 45: 3018

    PubMed  CAS  Google Scholar 

  221. Silverberg SG, Major FJ, Blessing JA, et al. (1990) Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. Int J Gynecol Pathol 9: 1–19

    PubMed  CAS  Google Scholar 

  222. Silverberg SG (1981) Significance of squamous elements in carcinoma of the endometrium: A review. Prog Surg Pathol 4: 115

    Google Scholar 

  223. Silverberg SG, Kurman RJ (1992) Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of tumor pathology. Third Series Fascicle, Armed Forces Institute of Pathology, Washington, DC, p 82

    Google Scholar 

  224. Simon A, Kopolovic J, Beyth Y (1988) Primary squamous cell carcinoma of the endometrium. Gynecol Oncol 31: 454–461

    PubMed  CAS  Google Scholar 

  225. Slot E (1980) Cytogenetics of carcinoma of the endometrium. I. The study on ploidy. Neoplasia 27: 483–488

    CAS  Google Scholar 

  226. Smith DC, Prentice R, Thompson DJ, Hermann WL (1975) Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 293: 1164

    PubMed  CAS  Google Scholar 

  227. Smith J, Yeh G (1992) Telomere reduction in endometrial adenocarcinoma. Am J Obstet Gynecol 167: 1883–1887

    PubMed  CAS  Google Scholar 

  228. Smith M, McCartney AJ (1985) Occult, high-risk endometrial cancer. Gynecol Oncol 22: 154

    PubMed  Google Scholar 

  229. Soisson AP, Berchuck A, Lessey BA, et al. (1989) Immunohistochemical expression of TAG-72 in normal and malignant endometrium: Correlation of antigen expression with estrogen receptor and progesterone receptor levels. Am J Obstet Gynecol 161: 1258–1263

    PubMed  CAS  Google Scholar 

  230. Steinhorn SC, Myers MH, Hankey BF, Pelham VF (1986) Factors associated with survival differences between black and white women with cancer of the uterine corpus. Am J Epidemiol 124: 85–93

    PubMed  CAS  Google Scholar 

  231. Stendahl U, Strang P, Wagenius G, Bergstrom R, Tribukait B (1991) Prognostic significance of proliferation in endometrial adenocarcinomas: A multivariate analysis of clinical and flow cytometric variables. Int J Gynecol Pathol 10: 271–284

    PubMed  CAS  Google Scholar 

  232. Suit HD, Gallagher HS (1964) Intact tumor cells in irradiated tissue. Arch Pathol 78: 648

    PubMed  CAS  Google Scholar 

  233. Sutton GP, Brill L, Michael H, Stehman FB, Ehrlich CE (1987) Malignant papillary lesions of the endometrium. Gynecol Oncol 27: 294–304

    PubMed  CAS  Google Scholar 

  234. Suzuki A, Konishi I, Okamura H, Makashima N (1984) Adenocarcinoma of the endometrium associated with intrauterine pregnancy. Gynecol Oncol 18: 261–269

    PubMed  CAS  Google Scholar 

  235. Thor A, Vigilone MJ, Muraro R, Ohuchi N, Schlom J, Gorstein F (1987) Monoclonal antibody B72.3 reactivity with human endometrium: A study of normal and malignant tissues. Int J Gynecol Pathol 6: 235–247

    PubMed  CAS  Google Scholar 

  236. Thrasher TV, Richart RM (1972) An ultrastructural comparison of endometrial adenocarcinoma and normal endometrium. Cancer 29: 1713

    PubMed  CAS  Google Scholar 

  237. Tiltman AJ (1980) Mucinous carcinoma of the endometrium. Obstet Gynecol 55: 244

    PubMed  CAS  Google Scholar 

  238. Tobon H, Watkins GJ (1985) Secretory adenocarcinoma of the endometrium. Int J Gynecol Pathol 4: 328

    PubMed  CAS  Google Scholar 

  239. Tornos C, Silva EG, El-Naggar A, Burke TW (1992) Aggressive stage 1 and grade 1 endometrial carcinoma. Cancer 70: 790–798

    PubMed  CAS  Google Scholar 

  240. Tseng PC, Sprance HE, Carcangiu ML, Chambers JT, Schwartz PE (1989) CA125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma. Obstet Gynecol 74: 384–386

    PubMed  CAS  Google Scholar 

  241. Tubiana M (1971) The kinetics of tumour cell proliferation and radiotherapy. Br J Radiol 44: 325

    PubMed  CAS  Google Scholar 

  242. Turner DA, Gershenson DM, Atkinson N, Sneige N, Wharton AT (1989) The prognostic significance of peritoneal cytology for Stage 1 endometrial cancer. Obstet Gynecol 74: 775–780

    PubMed  CAS  Google Scholar 

  243. Ueda G, Yamasaki M, Inoue M, Kurachi K (1979) A clinicopathologic study of endometrial carcinomas with argyrophil cells. Gynecol Oncol 7: 223

    PubMed  CAS  Google Scholar 

  244. Ueda G, Sato Y, Yamasaki M, et al (1978) Argyrophil cell adenocarcinoma of the endometrium. Gynecol Oncol 6: 467

    PubMed  CAS  Google Scholar 

  245. Ulbright TM, Roth LM (1985) Metastatic and independent cancers of the endometrium and ovary: A clinicopathologic study of 34 cases. Hum Pathol 16: 28

    PubMed  CAS  Google Scholar 

  246. Van Dam PA, Watson JV, Lowe DG, Shepherd JH (1992) Flow cytometric DNA analysis in gynecological oncology. Int J Gynecol Cancer 2: 57–65

    PubMed  Google Scholar 

  247. Vardi JR, Tadros GH, Zafaranloo S, Kapadia L, Alderete MN, Shebes ML (1989) Case report. Stage IV endometrial carcinoma in a 25-year-old woman: A case report and review of the literature. Gynecol Oncol 34: 244–248

    PubMed  CAS  Google Scholar 

  248. Vogel HP, Mendelsohn G (1987) Laminin immunostaining in hyperplastic, dysplastic and neoplastic lesions of the endometrium and the uterine cervix. Obstet Gynecol 69: 794–799

    PubMed  CAS  Google Scholar 

  249. Wahlstrom T, Korhonen M, Lindgren J, Markku S (1979) Distinction between endocervical and endometrial adenocarcinoma with immunoperoxidase staining of carcinoembryonic antigen in routine histologic tissue sections. Lancet 2: 1159

    PubMed  CAS  Google Scholar 

  250. Walker AM, Jick H (1979) Cancer of the corpus uteri: Increasing incidence in the United States. Am J Epidemiol 110: 47

    PubMed  CAS  Google Scholar 

  251. Walker AM, Jick H (1980) Declining rates of endometrial cancer. Obstet Gynecol 56: 733

    PubMed  CAS  Google Scholar 

  252. Ward B, Wright RK (1990) Free papillary carcinoma of the endometrium. Gynecol Oncol 39: 347–351

    PubMed  CAS  Google Scholar 

  253. Warhol MJ, Rice RH, Pinkus GS, Robboy SJ (1984) Evaluation of squamous epithelium in adenoacanthoma and adenosquamous carcinoma of the endometrium: Immunoperoxidase analysis of involucrin and keratin localization. Int J Gynecol Pathol 3: 82–91

    PubMed  CAS  Google Scholar 

  254. Warren S (1961) The pathology of ionizing radiation. Springfield, 111, Charles C Thomas

    Google Scholar 

  255. Way S (1954) The aetiology of carcinoma of the body of the uterus. J Obstet Gynaecol Br Emp 61: 46

    PubMed  CAS  Google Scholar 

  256. Webb GA, Lagios MD (1987) Clear cell carcinoma of the endometrium. Am J Obstet Gynecol 156: 1486–1491

    PubMed  CAS  Google Scholar 

  257. Weiner J, Bigelow B, Demopoulis RI (1980) The value of endocervical sampling in the staging of endometrial carcinoma. Diag Gynecol Obstet 2: 265

    CAS  Google Scholar 

  258. Wick MR, Nappi O (1993) Sarcomatoid carcinomas and carcinosarcomas. Semin Diag Pathol 10: 117–201

    Google Scholar 

  259. Wilkinson N, Buckley CH, Chawner L, Fox H (1990) Nucleolar organizer regions in normal, hyperplastic and neoplastic endometria. Int J Gynecol Pathol 9: 55–59

    PubMed  CAS  Google Scholar 

  260. Wynder EL, Escher GC, Mantel N (1966) An epidemiological investigation of cancer of the endometrium. Cancer 19: 489

    PubMed  CAS  Google Scholar 

  261. Yabushita H, Masuda T, Sawaguchi K, et al (1992) Growth potential of endometrial cancers assessed by a Ki-67 Ag/DNA dual-color flow-cytometric assay. Gynecol Oncol 44: 263–267

    PubMed  CAS  Google Scholar 

  262. Yazigi R, Piver MS, Blumenson L (1983) Malignant peritoneal cytology as a prognostic indicator in stage I endometrial cancer. Obstet Gynecol 62: 359

    PubMed  CAS  Google Scholar 

  263. Yoonessi M, Anderson DG, Morley GW (1979) Endometrial carcinoma: Causes of death and sites of treatment failure. Cancer 43: 1944

    PubMed  CAS  Google Scholar 

  264. Yorishima M, Hiura M, Moriwaki S, et al (1989) Clear cell carcinoma of the endometrium with lipid-producing activity. Int J Gynecol Pathol 8: 286–295

    PubMed  CAS  Google Scholar 

  265. Young RH, Scully RE (1992) Uterine carcinomas simulating microglandular hyperplasia. Am J Surg Pathol 16: 1092–1097

    PubMed  CAS  Google Scholar 

  266. Zaino RJ, Stayaswaroop PG, Mortel R (1984) Morphology of human uterine cancer in nude mice. Effects of hormone and antihormone treatment. Arch Pathol Lab Med 108: 571–578

    PubMed  CAS  Google Scholar 

  267. Zaino RJ, Clarke CL, Mortel R, Satyaswaroop PG (1988) Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma. Cancer Res 48: 1889–1895

    PubMed  CAS  Google Scholar 

  268. Zaino RJ, Kurman RJ (1988) Squamous differentiation in carcinoma of the endometrium: A critical appraisal of adenoacanthoma and adenosquamous carcinoma. Semin Diagn Pathol 5: 154–171

    PubMed  CAS  Google Scholar 

  269. Zaino RJ, Kurman RJ, Herbold D, et al. (1991) The significance of squamous differentiation in endometrial carcinoma: Data from a Gynecologic Oncology Group study. Cancer 68: 2293–3202

    PubMed  CAS  Google Scholar 

  270. Zaino RJ, Diana KL, Kurman RJ (unpublished data)

    Google Scholar 

  271. Ziel HK, Finkle WD (1975) Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 293: 1167

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Robert J. Kurman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard J. Zaino M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henry J. Norris M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Gynecology and Obstetrics and Pathology, The Johns Hopkins Hospital and The Johns Hopkins University, School of Medicine, Baltimore, MD, 21287, USA

    Robert J. Kurman M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kurman, R.J., Zaino, R.J., Norris, H.J. (1994). Endometrial Carcinoma. In: Kurman, R.J. (eds) Blaustein’s Pathology of the Female Genital Tract. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3889-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3889-6_12

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-3891-9

  • Online ISBN: 978-1-4757-3889-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation